Copyright Reports & Markets. All rights reserved.

Global Rosuvastatin and Ezetimibe Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Rosuvastatin and Ezetimibe Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Hospital
    • 1.3.3 Retail
    • 1.3.4 Online
  • 1.4 Market Analysis by Dosage Form
    • 1.4.1 Overview: Global Rosuvastatin and Ezetimibe Tablets Consumption Value by Dosage Form: 2021 Versus 2025 Versus 2032
    • 1.4.2 ：Film-coated Tablets
    • 1.4.3 Sustained-release Tablets
  • 1.5 Market Analysis by Specification
    • 1.5.1 Overview: Global Rosuvastatin and Ezetimibe Tablets Consumption Value by Specification: 2021 Versus 2025 Versus 2032
    • 1.5.2 10 mg/10 mg
    • 1.5.3 10 mg/5 mg
  • 1.6 Market Analysis by Production Technology
    • 1.6.1 Overview: Global Rosuvastatin and Ezetimibe Tablets Consumption Value by Production Technology: 2021 Versus 2025 Versus 2032
    • 1.6.2 Original Drug
    • 1.6.3 Generic Drug
  • 1.7 Market Analysis by Application
    • 1.7.1 Overview: Global Rosuvastatin and Ezetimibe Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.7.2 Hypercholesterolemia
    • 1.7.3 Cardiovascular
    • 1.7.4 Coronary Artery Disease
    • 1.7.5 Myocardial Infarction
    • 1.7.6 Others
  • 1.8 Global Rosuvastatin and Ezetimibe Tablets Market Size & Forecast
    • 1.8.1 Global Rosuvastatin and Ezetimibe Tablets Consumption Value (2021 & 2025 & 2032)
    • 1.8.2 Global Rosuvastatin and Ezetimibe Tablets Sales Quantity (2021-2032)
    • 1.8.3 Global Rosuvastatin and Ezetimibe Tablets Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 AstraZeneca
    • 2.1.1 AstraZeneca Details
    • 2.1.2 AstraZeneca Major Business
    • 2.1.3 AstraZeneca Rosuvastatin and Ezetimibe Tablets Product and Services
    • 2.1.4 AstraZeneca Rosuvastatin and Ezetimibe Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 AstraZeneca Recent Developments/Updates
  • 2.2 Merck
    • 2.2.1 Merck Details
    • 2.2.2 Merck Major Business
    • 2.2.3 Merck Rosuvastatin and Ezetimibe Tablets Product and Services
    • 2.2.4 Merck Rosuvastatin and Ezetimibe Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Merck Recent Developments/Updates
  • 2.3 Huahai Pharmaceutical
    • 2.3.1 Huahai Pharmaceutical Details
    • 2.3.2 Huahai Pharmaceutical Major Business
    • 2.3.3 Huahai Pharmaceutical Rosuvastatin and Ezetimibe Tablets Product and Services
    • 2.3.4 Huahai Pharmaceutical Rosuvastatin and Ezetimibe Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Huahai Pharmaceutical Recent Developments/Updates
  • 2.4 Aurobindo Pharma
    • 2.4.1 Aurobindo Pharma Details
    • 2.4.2 Aurobindo Pharma Major Business
    • 2.4.3 Aurobindo Pharma Rosuvastatin and Ezetimibe Tablets Product and Services
    • 2.4.4 Aurobindo Pharma Rosuvastatin and Ezetimibe Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Aurobindo Pharma Recent Developments/Updates

3 Competitive Environment: Rosuvastatin and Ezetimibe Tablets by Manufacturer

  • 3.1 Global Rosuvastatin and Ezetimibe Tablets Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Rosuvastatin and Ezetimibe Tablets Revenue by Manufacturer (2021-2026)
  • 3.3 Global Rosuvastatin and Ezetimibe Tablets Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Rosuvastatin and Ezetimibe Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Rosuvastatin and Ezetimibe Tablets Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Rosuvastatin and Ezetimibe Tablets Manufacturer Market Share in 2025
  • 3.5 Rosuvastatin and Ezetimibe Tablets Market: Overall Company Footprint Analysis
    • 3.5.1 Rosuvastatin and Ezetimibe Tablets Market: Region Footprint
    • 3.5.2 Rosuvastatin and Ezetimibe Tablets Market: Company Product Type Footprint
    • 3.5.3 Rosuvastatin and Ezetimibe Tablets Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Rosuvastatin and Ezetimibe Tablets Market Size by Region
    • 4.1.1 Global Rosuvastatin and Ezetimibe Tablets Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Rosuvastatin and Ezetimibe Tablets Consumption Value by Region (2021-2032)
    • 4.1.3 Global Rosuvastatin and Ezetimibe Tablets Average Price by Region (2021-2032)
  • 4.2 North America Rosuvastatin and Ezetimibe Tablets Consumption Value (2021-2032)
  • 4.3 Europe Rosuvastatin and Ezetimibe Tablets Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Rosuvastatin and Ezetimibe Tablets Consumption Value (2021-2032)
  • 4.5 South America Rosuvastatin and Ezetimibe Tablets Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Rosuvastatin and Ezetimibe Tablets Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Rosuvastatin and Ezetimibe Tablets Sales Quantity by Type (2021-2032)
  • 5.2 Global Rosuvastatin and Ezetimibe Tablets Consumption Value by Type (2021-2032)
  • 5.3 Global Rosuvastatin and Ezetimibe Tablets Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Rosuvastatin and Ezetimibe Tablets Sales Quantity by Application (2021-2032)
  • 6.2 Global Rosuvastatin and Ezetimibe Tablets Consumption Value by Application (2021-2032)
  • 6.3 Global Rosuvastatin and Ezetimibe Tablets Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Rosuvastatin and Ezetimibe Tablets Sales Quantity by Type (2021-2032)
  • 7.2 North America Rosuvastatin and Ezetimibe Tablets Sales Quantity by Application (2021-2032)
  • 7.3 North America Rosuvastatin and Ezetimibe Tablets Market Size by Country
    • 7.3.1 North America Rosuvastatin and Ezetimibe Tablets Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Rosuvastatin and Ezetimibe Tablets Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Rosuvastatin and Ezetimibe Tablets Sales Quantity by Type (2021-2032)
  • 8.2 Europe Rosuvastatin and Ezetimibe Tablets Sales Quantity by Application (2021-2032)
  • 8.3 Europe Rosuvastatin and Ezetimibe Tablets Market Size by Country
    • 8.3.1 Europe Rosuvastatin and Ezetimibe Tablets Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Rosuvastatin and Ezetimibe Tablets Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Rosuvastatin and Ezetimibe Tablets Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Rosuvastatin and Ezetimibe Tablets Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Rosuvastatin and Ezetimibe Tablets Market Size by Region
    • 9.3.1 Asia-Pacific Rosuvastatin and Ezetimibe Tablets Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Rosuvastatin and Ezetimibe Tablets Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Rosuvastatin and Ezetimibe Tablets Sales Quantity by Type (2021-2032)
  • 10.2 South America Rosuvastatin and Ezetimibe Tablets Sales Quantity by Application (2021-2032)
  • 10.3 South America Rosuvastatin and Ezetimibe Tablets Market Size by Country
    • 10.3.1 South America Rosuvastatin and Ezetimibe Tablets Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Rosuvastatin and Ezetimibe Tablets Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Rosuvastatin and Ezetimibe Tablets Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Rosuvastatin and Ezetimibe Tablets Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Rosuvastatin and Ezetimibe Tablets Market Size by Country
    • 11.3.1 Middle East & Africa Rosuvastatin and Ezetimibe Tablets Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Rosuvastatin and Ezetimibe Tablets Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Rosuvastatin and Ezetimibe Tablets Market Drivers
  • 12.2 Rosuvastatin and Ezetimibe Tablets Market Restraints
  • 12.3 Rosuvastatin and Ezetimibe Tablets Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Rosuvastatin and Ezetimibe Tablets and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Rosuvastatin and Ezetimibe Tablets
  • 13.3 Rosuvastatin and Ezetimibe Tablets Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Rosuvastatin and Ezetimibe Tablets Typical Distributors
  • 14.3 Rosuvastatin and Ezetimibe Tablets Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Rosuvastatin and Ezetimibe Tablets market size was valued at US$ 134 million in 2025 and is forecast to a readjusted size of US$ 841 million by 2032 with a CAGR of 14.6% during review period.
    Rosuvastatin and Ezetimibe Tablets are a fixed-dose combination lipid-lowering drug formulated with rosuvastatin and ezetimibe. Through dual synergistic mechanisms—inhibiting hepatic cholesterol synthesis and blocking intestinal cholesterol absorption—they potently reduce total cholesterol, low-density lipoprotein cholesterol and triglycerides, while moderately increasing high-density lipoprotein cholesterol.
    This product is mainly indicated for primary hypercholesterolemia and mixed hyperlipidemia, and can also be used as adjunctive therapy for homozygous familial hypercholesterolemia. It is suitable for patients who fail to achieve adequate lipid control with statin monotherapy. Featuring high lipid-lowering efficacy, good medication adherence and controllable safety, it is a commonly used compound preparation in clinical lipid management and cardiovascular risk prevention.In 2025, global Rosuvastatin and Ezetimibe Tablets production reached approximately 250 million bottles.
    Rosuvastatin Ezetimibe Tablets are a combination formulation of rosuvastatin and ezetimibe, primarily used to treat hypercholesterolemia and reduce the risk of cardiovascular events. With the rising global incidence of cardiovascular diseases and increasing public health awareness, the demand for cholesterol-lowering drugs continues to grow. Rosuvastatin Ezetimibe Tablets, with their dual lipid-lowering action, effectively reduce low-density lipoprotein cholesterol (LDL-C), making them especially suitable for patients who do not respond well to single statin therapy or other lipid-lowering treatments. As a result, they have broad application prospects in high-risk cardiovascular disease patients.
    In terms of market demand, due to the high prevalence of cardiovascular diseases, the demand for Rosuvastatin Ezetimibe Tablets shows a sustained growth trend. This is especially true in an aging society and against the backdrop of increasing lifestyle-related diseases, where more patients require more comprehensive treatment approaches to control cholesterol levels.
    This report is a detailed and comprehensive analysis for global Rosuvastatin and Ezetimibe Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Rosuvastatin and Ezetimibe Tablets market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Rosuvastatin and Ezetimibe Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Rosuvastatin and Ezetimibe Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Rosuvastatin and Ezetimibe Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Rosuvastatin and Ezetimibe Tablets
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Rosuvastatin and Ezetimibe Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Merck, Huahai Pharmaceutical, Aurobindo Pharma, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Rosuvastatin and Ezetimibe Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Hospital
    Retail
    Online
    Market segment by Dosage Form
    ：Film-coated Tablets
    Sustained-release Tablets
    Market segment by Specification
    10 mg/10 mg
    10 mg/5 mg
    Market segment by Production Technology
    Original Drug
    Generic Drug
    Market segment by Application
    Hypercholesterolemia
    Cardiovascular
    Coronary Artery Disease
    Myocardial Infarction
    Others
    Major players covered
    AstraZeneca
    Merck
    Huahai Pharmaceutical
    Aurobindo Pharma
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Rosuvastatin and Ezetimibe Tablets product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Rosuvastatin and Ezetimibe Tablets, with price, sales quantity, revenue, and global market share of Rosuvastatin and Ezetimibe Tablets from 2021 to 2026.
    Chapter 3, the Rosuvastatin and Ezetimibe Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Rosuvastatin and Ezetimibe Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Rosuvastatin and Ezetimibe Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Rosuvastatin and Ezetimibe Tablets.
    Chapter 14 and 15, to describe Rosuvastatin and Ezetimibe Tablets sales channel, distributors, customers, research findings and conclusion.

    Buy now